THXID™-BRAF
BioMerieux, Inc.
| Registration | FEI | Name | Status | Initial importer | Expiration year | Address |
|---|---|---|---|---|---|---|
| 1450405 | 1450405 | BIOMERIEUX, INC. | 1 | N | 2026-01-01 | 1105 N Main St LOMBARD IL US 60148 |
| 1950204 | 1950204 | BIOMERIEUX, INC. | 1 | Y | 2026-01-01 | 595 ANGLUM RD. HAZELWOOD MO US 63042 |
| 3002769706 | 3002769706 | BIOMERIEUX, INC. | 1 | N | 2026-01-01 | 100 RODOLPHE ST DURHAM NC US 27712 |
| 3025775667 | 3025775667 | BIOMERIEUX, INC. | 1 | N | 2026-01-01 | 1201 S 4800 W Salt Lake City UT US 84104 |
| 3031977134 | 3031977134 | bioMerieux, Inc. | 1 | N | 2026-01-01 | 3015 Carrington Mill Blvd Morrisville NC US 27560 |
| Registration key | Listing key | Premarket submission | Device | Product code | Decision date |
|---|---|---|---|---|---|
| 9759 | 1564096010 | N50510 | VITEK SYSTEMS GENERAL SUSCEPTIBILITY CARD | LTW | 1978-03-02 |
| 330867 | 1564096010 | N50510 | VITEK SYSTEMS GENERAL SUSCEPTIBILITY CARD | LTW | 1978-03-02 |
| 342170 | 1564096010 | N50510 | VITEK SYSTEMS GENERAL SUSCEPTIBILITY CARD | LTW | 1978-03-02 |
| 9759 | 1719697936 | K981736 | BACT/ALERT 3D MICROBIAL DETECTION SYSTEM | MDB | 1998-07-24 |
| 330867 | 1719697936 | K981736 | BACT/ALERT 3D MICROBIAL DETECTION SYSTEM | MDB | 1998-07-24 |
| 9759 | 1368307575 | K962609 | GRAM NEGATIVE IDENTIFICATION PLUS CARD | LRH | 1996-08-30 |
| 9756 | 1067684892 | K933939 | BACT/ALERT BLOOD COLLECTION ADAPTER CAP AND INSERT | GIM | 1994-02-07 |
| 9759 | 1825208256 | K910666 | VITEK ANAEROBE IDENTIFICATION CARD, MODIFICATION | JSP | 1991-04-03 |
| 9759 | 2035124959 | K910304 | RAPID CORYNE SYST/IDENTIF OF CORYNEFORM BACTERIA | LQL | 1991-07-26 |
| 9759 | 1668132539 | K903505 | BACT/ALERT (TM) | MDB | 1991-03-12 |
| 330867 | 1668132539 | K903505 | BACT/ALERT (TM) | MDB | 1991-03-12 |
| 9759 | 1332586277 | K881925 | VITEK YEAST BIOCHEMICAL CARD | JXB | 1988-06-16 |
| 9759 | 1563916653 | K260619 | |||
| 9759 | 1593912752 | K260282 | VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance | LON | 2026-04-15 |
| 9759 | 1673548259 | K260281 | VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL) | LON | 2026-03-26 |
| 9759 | 1782890459 | K260160 | VITEK REVEAL GN AST Assay and VITEK REVEAL AST System | SAN | 2026-07-08 |
| 9759 | 1817280878 | K251579 | VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL) | LON | 2025-08-21 |
| 9759 | 1991303695 | K234012 | VITEK COMPACT PRO | LON | 2025-03-14 |
| 9759 | 1428133906 | K234000 | VITEK 2 AST-Gram Positive Lefamulin (<=0.03 - >=4 µg/mL) | LON | 2024-03-11 |
| 330867 | 1428133906 | K234000 | VITEK 2 AST-Gram Positive Lefamulin (<=0.03 - >=4 µg/mL) | LON | 2024-03-11 |
| 9759 | 1231259373 | K232967 | VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 µg/mL) | NGZ | 2024-06-12 |
| 330867 | 1231259373 | K232967 | VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 µg/mL) | NGZ | 2024-06-12 |
| 9759 | 1398877114 | K232963 | VITEK 2 AST-Yeast Anidulafungin (<= 0.015 - >= 8 µg/mL) | NGZ | 2024-06-07 |
| 330867 | 1398877114 | K232963 | VITEK 2 AST-Yeast Anidulafungin (<= 0.015 - >= 8 µg/mL) | NGZ | 2024-06-07 |
| 9759 | 2065733366 | K232201 | VITEK 2 AST-Streptococcus Penicillin (<=0.06 - =>8 µg/mL), VITEK 2 Streptococcus Penicillin (<=0.06 - >=8 µg/mL), VITEK 2 Streptococcus Penicillin | LON | 2023-10-23 |
| 330867 | 2065733366 | K232201 | VITEK 2 AST-Streptococcus Penicillin (<=0.06 - =>8 µg/mL), VITEK 2 Streptococcus Penicillin (<=0.06 - >=8 µg/mL), VITEK 2 Streptococcus Penicillin | LON | 2023-10-23 |
| 9759 | 1745152233 | K230864 | VITEK 2 AST-Gram Positive Daptomycin (<=0.12 - >=8 µg/mL), VITEK 2 AST-GP Daptomycin (<=0.12 - >=8 µg/mL), VITEK 2 AST-GP Daptomycin | LON | 2023-07-05 |
| 330867 | 1745152233 | K230864 | VITEK 2 AST-Gram Positive Daptomycin (<=0.12 - >=8 µg/mL), VITEK 2 AST-GP Daptomycin (<=0.12 - >=8 µg/mL), VITEK 2 AST-GP Daptomycin | LON | 2023-07-05 |
| 9759 | 1047179699 | K230675 | VITEK REVEAL GN AST Assay and VITEK REVEAL AST System | SAN | 2024-06-20 |
| 9759 | 1627179255 | K223481 | VITEK® 2 Streptococcus Tetracycline (<=0.25 - >=16 µg/mL) | LON | 2023-02-03 |
| 330867 | 1627179255 | K223481 | VITEK® 2 Streptococcus Tetracycline (<=0.25 - >=16 µg/mL) | LON | 2023-02-03 |
| 9759 | 1553255155 | K223478 | VITEK® 2 AST-Gram Negative Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin | LON | 2023-02-16 |
| 330867 | 1553255155 | K223478 | VITEK® 2 AST-Gram Negative Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin | LON | 2023-02-16 |
| 9759 | 1381519264 | K222430 | VITEK 2 AST-Gram Negative Fosfomycin (<=4 - >=256 µg/mL), VITEK 2 AST-GN Fosfomycin (<=4 - >=256 µg/mL), VITEK 2 AST-GN Fosfomycin | LON | 2023-03-09 |
| 330867 | 1381519264 | K222430 | VITEK 2 AST-Gram Negative Fosfomycin (<=4 - >=256 µg/mL), VITEK 2 AST-GN Fosfomycin (<=4 - >=256 µg/mL), VITEK 2 AST-GN Fosfomycin | LON | 2023-03-09 |
| 9759 | 1474667258 | K222378 | VITEK 2 AST-Gram Negative Levofloxacin (</=0.125 ->/=8 ug/mL) | LON | 2023-06-26 |
| 330867 | 1474667258 | K222378 | VITEK 2 AST-Gram Negative Levofloxacin (</=0.125 ->/=8 ug/mL) | LON | 2023-06-26 |
| 9759 | 1407256092 | K222073 | VITEK 2 AST-Gram Negative Cefazolin (<=1 - >=32 ug/mL) | LON | 2023-02-09 |
| 330867 | 1407256092 | K222073 | VITEK 2 AST-Gram Negative Cefazolin (<=1 - >=32 ug/mL) | LON | 2023-02-09 |
| 9759 | 1206437726 | K220805 | VITEK 2 AST-Gram Positive Cefoxitin Screen | LON | 2022-10-13 |
| 330867 | 1206437726 | K220805 | VITEK 2 AST-Gram Positive Cefoxitin Screen | LON | 2022-10-13 |
| 9759 | 1605615652 | K220803 | VITEK 2 AST-Gram Positive Moxifloxacin (=0.25 - =8 µg/ml), VITEK 2 AST-GP Moxifloxacin (=0.25 - =8 µg/mL), VITEK 2 AST-GP Moxifloxacin | LON | 2023-01-27 |
| 330867 | 1605615652 | K220803 | VITEK 2 AST-Gram Positive Moxifloxacin (=0.25 - =8 µg/ml), VITEK 2 AST-GP Moxifloxacin (=0.25 - =8 µg/mL), VITEK 2 AST-GP Moxifloxacin | LON | 2023-01-27 |
| 9759 | 1817842505 | K214023 | VITEK 2 AST-Gram Negative Ciprofloxacin (?0.06 - ?4 µg/mL) | LON | 2022-04-14 |
| 330867 | 1817842505 | K214023 | VITEK 2 AST-Gram Negative Ciprofloxacin (?0.06 - ?4 µg/mL) | LON | 2022-04-14 |
| 9759 | 1159861971 | K213931 | VITEK 2 AST-Gram Negative Omadacycline (<=0.25 - >=16 µg/mL) | LON | 2022-06-03 |
| 330867 | 1159861971 | K213931 | VITEK 2 AST-Gram Negative Omadacycline (<=0.25 - >=16 µg/mL) | LON | 2022-06-03 |
| 9759 | 1624805318 | K213899 | VITEK 2 AST-Yeast Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-YS Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-YS Caspofungin | LON | 2022-07-12 |
| 330867 | 1624805318 | K213899 | VITEK 2 AST-Yeast Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-YS Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-YS Caspofungin | LON | 2022-07-12 |
| 9759 | 1402319659 | K213241 | VITEK 2 AST-Yeast Fluconazole (<=0.5->=64 µg/mL), VITEK 2 AST-YS Fluconazole (<=0.5->=64 µg/mL), VITEK 2 AST-YS Fluconazole | LON | 2022-02-25 |
| 330867 | 1402319659 | K213241 | VITEK 2 AST-Yeast Fluconazole (<=0.5->=64 µg/mL), VITEK 2 AST-YS Fluconazole (<=0.5->=64 µg/mL), VITEK 2 AST-YS Fluconazole | LON | 2022-02-25 |
| 9759 | 2004365094 | K212849 | VITEK 2 AST-Gram Positive Linezolid (<=0.5 – >=8 µg/mL) | LON | 2022-02-04 |
| 330867 | 2004365094 | K212849 | VITEK 2 AST-Gram Positive Linezolid (<=0.5 – >=8 µg/mL) | LON | 2022-02-04 |
| 9759 | 1595386780 | K212243 | VITEK 2 AST- Gram Positive Telavancin (<=0.015 - >=1 µg/mL) | LON | 2022-08-08 |
| 330867 | 1595386780 | K212243 | VITEK 2 AST- Gram Positive Telavancin (<=0.015 - >=1 µg/mL) | LON | 2022-08-08 |
| 9759 | 1187639540 | K211630 | VITEK 2 AST-Gram Negative Piperacillin / Tazobactam (<=4 - =>128 µg/mL) | LON | 2021-08-30 |
| 330867 | 1187639540 | K211630 | VITEK 2 AST-Gram Negative Piperacillin / Tazobactam (<=4 - =>128 µg/mL) | LON | 2021-08-30 |
| 9759 | 1455172546 | K211136 | VITEK 2 AST-Gram Negative Imipenem/Relebactam (<0.25/4 - >16/4 ug/ML) | LON | 2021-06-14 |
| 330867 | 1455172546 | K211136 | VITEK 2 AST-Gram Negative Imipenem/Relebactam (<0.25/4 - >16/4 ug/ML) | LON | 2021-06-14 |
| 9759 | 1118608189 | K210287 | VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL) | LON | 2021-10-28 |
| 330867 | 1118608189 | K210287 | VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL) | LON | 2021-10-28 |
| 9759 | 2016796042 | K202396 | VITEK 2 AST-Gram Positive Fosfomycin (<=8 - >=256 ug/mL) | LON | 2021-09-14 |
| 330867 | 2016796042 | K202396 | VITEK 2 AST-Gram Positive Fosfomycin (<=8 - >=256 ug/mL) | LON | 2021-09-14 |
| 9759 | 1812779869 | K201675 | VITEK 2 AST-Gram Negative Meropenem (<= 0.25 - >=16 µg/mL) | LON | 2021-07-09 |
| 330867 | 1812779869 | K201675 | VITEK 2 AST-Gram Negative Meropenem (<= 0.25 - >=16 µg/mL) | LON | 2021-07-09 |
| 9759 | 1132359229 | K200590 | VITEK 2 AST-Gram Positive Delafloxacin (<=0.015 - >=1 µg/mL) | LON | 2020-04-28 |
| 330867 | 1132359229 | K200590 | VITEK 2 AST-Gram Positive Delafloxacin (<=0.015 - >=1 µg/mL) | LON | 2020-04-28 |
| 9759 | 1951517469 | K193572 | VITEK 2 AST-Gram Negative Imipenem/Relebactam (<=0.25/4 - >=16/4 µg/mL) | LON | 2020-03-13 |
| 330867 | 1951517469 | K193572 | VITEK 2 AST-Gram Negative Imipenem/Relebactam (<=0.25/4 - >=16/4 µg/mL) | LON | 2020-03-13 |
| 9759 | 1453194829 | K193567 | VITEK 2 AST- Gram Negative Polymyxin B (<=0.25 – >=16 ug/mL) | LON | 2020-02-14 |
| 330867 | 1453194829 | K193567 | VITEK 2 AST- Gram Negative Polymyxin B (<=0.25 – >=16 ug/mL) | LON | 2020-02-14 |
| 9759 | 1320590281 | K193299 | VITEK 2 AST-Gram Negative Ceftazidime (=<0.5 - =>32 µg/mL) | LON | 2020-09-28 |
| 330867 | 1320590281 | K193299 | VITEK 2 AST-Gram Negative Ceftazidime (=<0.5 - =>32 µg/mL) | LON | 2020-09-28 |
| 9759 | 1379065502 | K192110 | Vitek Densichek | LON | 2019-10-31 |
| 330867 | 1379065502 | K192110 | Vitek Densichek | LON | 2019-10-31 |
| 9759 | 1004959614 | K191766 | VITEK 2 AST-Gram Negative Eravacycline (<=0.12 - >=4µg/mL) | LON | 2019-08-05 |
| 330867 | 1004959614 | K191766 | VITEK 2 AST-Gram Negative Eravacycline (<=0.12 - >=4µg/mL) | LON | 2019-08-05 |
| 9759 | 2026414414 | K190616 | VITEK 2 AST-Gram Positive Dalbavancin (<= 0.015 - >= 1 µg/mL) | LON | 2019-06-06 |
| 330867 | 2026414414 | K190616 | VITEK 2 AST-Gram Positive Dalbavancin (<= 0.015 - >= 1 µg/mL) | LON | 2019-06-06 |
| 9756 | 2035384580 | K190405 | BACT/ALERT MP Reagent System | MDB | 2019-05-15 |
| 330867 | 2035384580 | K190405 | BACT/ALERT MP Reagent System | MDB | 2019-05-15 |
| 9759 | 1708414493 | K183551 | VITEK 2 AST-Gram Negative Minocycline (<= 0.5 - >= 32 ug/mL) | LON | 2019-03-07 |
| 330867 | 1708414493 | K183551 | VITEK 2 AST-Gram Negative Minocycline (<= 0.5 - >= 32 ug/mL) | LON | 2019-03-07 |
| 9759 | 2070488037 | K183524 | VITEK2 AST-Gram Negative Delafloxacin (<=0.06->=4 ug/mL) | LON | 2019-03-12 |
| 330867 | 2070488037 | K183524 | VITEK2 AST-Gram Negative Delafloxacin (<=0.06->=4 ug/mL) | LON | 2019-03-12 |
| 9759 | 1669506464 | K183415 | VITEK 2 AST-Gram Negative Imipenem (</=0.25->= 16 ug/mL) | LON | 2019-02-20 |
| 330867 | 1669506464 | K183415 | VITEK 2 AST-Gram Negative Imipenem (</=0.25->= 16 ug/mL) | LON | 2019-02-20 |
| 9759 | 1924967931 | K183360 | VITEK 2 AST-Gram Negative Meropenem/Vaborbactam (<=0.5/8 – >=64/8 µg/mL) | LON | 2019-02-26 |
| 330867 | 1924967931 | K183360 | VITEK 2 AST-Gram Negative Meropenem/Vaborbactam (<=0.5/8 – >=64/8 µg/mL) | LON | 2019-02-26 |
| 9756 | 1664950732 | K183166 | BacT/ALERT FA Plus; BacT/ALERT PF Plus | MDB | 2019-02-11 |
| 330867 | 1664950732 | K183166 | BacT/ALERT FA Plus; BacT/ALERT PF Plus | MDB | 2019-02-11 |
| 9759 | 1867165198 | K181766 | VITEK 2 AST-Gram Positive Inducible Clindamycin Resistance | LON | 2018-12-10 |
| 330867 | 1867165198 | K181766 | VITEK 2 AST-Gram Positive Inducible Clindamycin Resistance | LON | 2018-12-10 |
| 9759 | 1378472382 | K172944 | VITEK 2 AST-GN Ceftazidime/Avibactam <=0.12 – >=16 µg/mL | LON | 2017-12-19 |
| 330867 | 1378472382 | K172944 | VITEK 2 AST-GN Ceftazidime/Avibactam <=0.12 – >=16 µg/mL | LON | 2017-12-19 |
| 9759 | 1029844055 | K172731 | VITEK 2 AST-GN Amikacin (<=1 ->=64 ug/mL) | LON | 2017-12-08 |
| 330867 | 1029844055 | K172731 | VITEK 2 AST-GN Amikacin (<=1 ->=64 ug/mL) | LON | 2017-12-08 |
| 9759 | 1310520682 | K163563 | VITEK 2 AST-GN Gentamicin (<=1 – >=16 µg/mL) | LON | 2017-03-13 |
| 330867 | 1310520682 | K163563 | VITEK 2 AST-GN Gentamicin (<=1 – >=16 µg/mL) | LON | 2017-03-13 |
| 9759 | 1456632838 | K163083 | VITEK 2 AST-GN Tobramycin (</=1->/= 16 ug/mL); VITEK 2 AST-Gram Negative Tobramycin (</=1->/=16 ug/mL) | LON | 2017-02-01 |
| 330867 | 1456632838 | K163083 | VITEK 2 AST-GN Tobramycin (</=1->/= 16 ug/mL); VITEK 2 AST-Gram Negative Tobramycin (</=1->/=16 ug/mL) | LON | 2017-02-01 |
| 9759 | 1883272043 | K163006 | VITEK 2 AST-GN Tigecycline (<0.5->8 ug/mL) | LON | 2017-01-24 |
| 330867 | 1883272043 | K163006 | VITEK 2 AST-GN Tigecycline (<0.5->8 ug/mL) | LON | 2017-01-24 |
| 9759 | 1533019471 | K162737 | VITEK 2 AST-GN Ciprofloxacin (<=0.06->=4µg/mL) | LON | 2017-06-21 |
| 330867 | 1533019471 | K162737 | VITEK 2 AST-GN Ciprofloxacin (<=0.06->=4µg/mL) | LON | 2017-06-21 |
| 9759 | 1615328219 | K161816 | BacT/ALERT VIRTUO Microbial Detection System, BacT/ALERT VIRTUO, VIRTUO | MDB | 2017-03-28 |
| 330867 | 1615328219 | K161816 | BacT/ALERT VIRTUO Microbial Detection System, BacT/ALERT VIRTUO, VIRTUO | MDB | 2017-03-28 |
| 9759 | 1511965374 | K161510 | VTEK 2 AST-GN Ceftolozane/Tazobactam (<=0.25 - >= 32 mcg/mL) | LON | 2017-02-13 |
| 330867 | 1511965374 | K161510 | VTEK 2 AST-GN Ceftolozane/Tazobactam (<=0.25 - >= 32 mcg/mL) | LON | 2017-02-13 |
| 9759 | 1455922687 | K161437 | VITEK 2 AST Gram Negative Cefotaxime (<=0.25 - >=64 ug/mL) | LON | 2017-02-16 |
| 330867 | 1455922687 | K161437 | VITEK 2 AST Gram Negative Cefotaxime (<=0.25 - >=64 ug/mL) | LON | 2017-02-16 |
| 9759 | 1948106343 | K161227 | VITEK 2 AST-GN Cefepime (<=0.12->=32 ug/mL) | LON | 2016-07-20 |
| 330867 | 1948106343 | K161227 | VITEK 2 AST-GN Cefepime (<=0.12->=32 ug/mL) | LON | 2016-07-20 |
| 9759 | 1068834959 | K161217 | VITEK 2 Gram Negative Ceftriaxone (<=0.25->=64 ug/mL) | LON | 2017-01-12 |
| 330867 | 1068834959 | K161217 | VITEK 2 Gram Negative Ceftriaxone (<=0.25->=64 ug/mL) | LON | 2017-01-12 |
| 9759 | 1990287935 | K152075 | VITEK 2 AST-Gram Negative Ertapenem (<=0.12 - >=8 ug/mL) | LON | 2016-04-15 |
| 330867 | 1990287935 | K152075 | VITEK 2 AST-Gram Negative Ertapenem (<=0.12 - >=8 ug/mL) | LON | 2016-04-15 |
| 9759 | 1146624721 | K151923 | VITEK 2 AST-Yeast Micafungin (0.06-8 mcg/mL) | NGZ | 2016-03-25 |
| 9759 | 1959467235 | K151817 | VITEK 2 AST-YS Caspofungin <=0.125 - >=8 ug/mL | NGZ | 2016-02-18 |
| 9759 | 1027756254 | K141149 | VITEK 2 AST GP CEFTAROLINE | LON | 2014-06-20 |
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
BioMerieux, Inc.
bioMerieux, Inc.
bioMerieux, Inc.
BioMerieux, Inc.
bioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.
BioMerieux, Inc.